Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: Caplyta

Posted by undopaminergic on January 17, 2020, at 14:10:30

In reply to Caplyta alexandra_k, posted by phidippus on January 17, 2020, at 12:07:55

> Caplyta. I found it.
> Lumateperone (INN; brand name Caplyta kəp-LY-tə, developmental codes ITI-007 and ITI-722) is a butyrophenone atypical antipsychotic developed by Intra-Cellular Therapies, licensed from Bristol-Myers Squibb, for the treatment of schizophrenia,[1] and currently in development for bipolar depression and other neurological indications.

Is bipolar depression a neurological indication now?





Post a new follow-up

Your message only Include above post

Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.


Start a new thread

Google www
Search options and examples
[amazon] for

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:undopaminergic thread:1107961